OmniSeq, UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer

Mar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

Mar

Featured Webinar

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.

Menu

OmniSeq, UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer

To read the full story....

Breaking News

Quanterix Q4 Revenues Up 64 Percent

NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications

Molecular Health Inks Agreement for Precision Medicine Tools With Falco Biosystems

Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs

Recent Headlines from
Precision Oncology News

Cartesian Therapeutics Bets on mRNA Engineering for Moving CAR T Cells Into Frontline Treatment

Elicio Therapeutics Sharpens Development Plan for Cancer Vaccine in KRAS-Mutated Tumors

CAR T-Cell Resistance Mechanism Shows Need for Multi-Antigen Targeted Immunotherapy Strategies

Benefit of AstraZeneca's Cediranib Plus Lynparza May Be Limited to HRR-Deficient Prostate Cancers

Fecal Transplants Boost Immunotherapy Response in Subset of Melanoma Patients

Featured White Papers

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

What's Popular?

Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year

TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine

Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

Sponsorships